AWHL
Aspira Women's Health Inc.
Key Financials
Net Income
$-12780000
↑ 2.4%
Revenue
$343000
↓ 91.4%
Gross Profit
$5.9M
↑ 8.0%
Operating Income
$-7913000
↑ 51.4%
Shareholders' Equity
$-6932000.00
↓ 170.5%
Total Assets
$5.5M
↓ 0.6%
EPS (Diluted)
$-0.37
↑ 60.2%
Total Liabilities
$12.4M
↑ 53.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/14/2026 | View on SEC |
| 4/A | 7/17/2026 | View on SEC |
| 4 | 7/15/2026 | View on SEC |
| 8-K | 7/15/2026 | View on SEC |
| 3 | 7/15/2026 | View on SEC |
| 8-K/A | 7/7/2026 | View on SEC |
| D | 6/22/2026 | View on SEC |
| 8-K | 6/22/2026 | View on SEC |
| 8-K | 6/17/2026 | View on SEC |
| SCHEDULE 13D/A | 6/11/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AWHL |
| Company Name | Aspira Women's Health Inc. |
| CIK | 926617 |
| Sector | In Vitro & In Vivo Diagnostic Substances |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2835 |
| SIC Description | In Vitro & In Vivo Diagnostic Substances |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 512-519-0400 |